Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Aitken

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Contemporary Clinical Trials|September 24, 2013
Rationale and design of a randomized trial of home electronic symptom and lung function monitoring to detect cystic fibrosis pulmonary exacerbations: the early intervention in cystic fibrosis exacerbation (eICE) trialN Lechtzin, N West, S Allgood, et al.
The American Review of Respiratory Disease|July 1, 1993
Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosisB W Ramsey, S J Astley, M L Aitken, et al.
Human Gene Therapy|October 9, 2001
A phase I study of aerosolized administration of tgAAVCF to cystic fibrosis subjects with mild lung diseaseM L Aitken, R B Moss, D A Waltz, et al.
The Journal of Pediatrics|July 1, 1997
Safety of repeated intermittent courses of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosisJ D Eisenberg, M L Aitken, H L Dorkin, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 4, 2021
Changes in fecal microbiota with CFTR modulator therapy: A pilot studyC E Pope, A T Vo, H S Hayden, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 30, 2020
Men's health in the modern era of cystic fibrosisF N Khan, V Tangpricha, K S Hughan, et al.
Pediatric Pulmonology|July 31, 2001
Safety of aerosolized INS 365 in patients with mild to moderate cystic fibrosis: results of a phase I multi-center studyP G Noone, N Hamblett, F Accurso, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Contemporary Clinical Trials|September 24, 2013
Rationale and design of a randomized trial of home electronic symptom and lung function monitoring to detect cystic fibrosis pulmonary exacerbations: the early intervention in cystic fibrosis exacerbation (eICE) trialN Lechtzin, N West, S Allgood, et al.
The American Review of Respiratory Disease|July 1, 1993
Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosisB W Ramsey, S J Astley, M L Aitken, et al.
Human Gene Therapy|October 9, 2001
A phase I study of aerosolized administration of tgAAVCF to cystic fibrosis subjects with mild lung diseaseM L Aitken, R B Moss, D A Waltz, et al.
The Journal of Pediatrics|July 1, 1997
Safety of repeated intermittent courses of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosisJ D Eisenberg, M L Aitken, H L Dorkin, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 4, 2021
Changes in fecal microbiota with CFTR modulator therapy: A pilot studyC E Pope, A T Vo, H S Hayden, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 30, 2020
Men's health in the modern era of cystic fibrosisF N Khan, V Tangpricha, K S Hughan, et al.
Pediatric Pulmonology|July 31, 2001
Safety of aerosolized INS 365 in patients with mild to moderate cystic fibrosis: results of a phase I multi-center studyP G Noone, N Hamblett, F Accurso, et al.
Pageof 6